Keratinocytes suppress transforming growth factor-β1 expression by fibroblasts in cultured skin substitutes

British Journal of Dermatology

Volumn 140, Issue 3, 1999, Pages 409-416

  Le Poole, I C ^a   Boyce, Steven T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cultured skin substitutes; Transforming growth factor 1; Wound healing

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL INTERACTION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; MELANOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WOUND HEALING;

BLOTTING, NORTHERN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTORS; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; MELANOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN, ARTIFICIAL; TRANSFORMING GROWTH FACTOR BETA; WOUND HEALING;

EID: 0032955041     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1999.02700.x     Document Type: Article

References (28)

1. 1 Glick AB, Kulkarni AB, Tennenbaum T et al. Loss of expression of transforming growth factor β in skin and skin tumors is associated with hyperproliferation and high risk for malignant conversion. Proc Natl Acad Sci USA 1943; 90: 6076-80.
2. 2 Derynck R, Jarrett JA, Chen AY et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 116: 701-5.
3. 3 O'Kane S, Ferguson MWJ. Transforming growth factor βs and wound healing. Int J Biochem Cell Biol 1997; 29: 63-78.
4. 4 Barcellos-Hoff MH. Latency and activation in the control of TGF-β. J Mamm Gland Biol Neoplas 1996; 1: 351-61.
5. 5 Munz B, Gerke V, Gillitzer R, Werner S. Differential expression of the calpactin I subunits annexin II and p11 in cultured keratinocytes and during wound repair. J Invest Dermatol 1997; 108: 307-12.
6. 6 Barcellos-Hoff MH, Derynck R, Tsang MLS, Weatherbee JA. Transforming growth factor-beta activation in irradiated murine mammary gland. J Clin Invest 1994; 93: 892-9.
7. 7 Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997; 276: 75-81.
8. 8 Sfikakis PP, McCune BK, Tsokos M et al. Immunohistological demonstration of transforming growth factor-β isoforms in the skin of patients with systemic sclerosis. Clin Immunol Immunopathol 1993; 69: 199-204.
9. 9 Compton C, Tong Y, Trookman N et al. TGF-β1 gene expression in cultured human keratinocytes does not decrease with biologic age. J Invest Dermatol 1994; 103: 127-33.
10. 10 Boyce ST. Skin repair with cultured cells and biopolymers. In: Human Biomaterials Applications (Wise DL et al., eds). Totowa, NJ: Humana Press, Inc., 1996; 347-77.
11. 11 Wei-kang S, Qin-wei Y, Lin-pin B. Biologic characterization of a monoclonal antibody TB21 against human transforming growth factor-beta 1. Acta Biol Exp Sin 1993; 26: 141-8.
12. 12 Frank S, Madlener M, Werner S. Transforming growth factors β1, β2 and β3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996; 271: 10188-93.
13. 13 Rodeck U, Bossler A, Graeven U et al. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res 1994; 54: 575-81.
14. 14 Boyce ST, Gorelsky MJ, Greenhalgh DG et al. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg 1995; 222: 743-52.
15. 15 Boyce ST, Ham RG. Calcium regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol 1983; 81: S33-40.
16. 16 Hansbrough JF, Boyce ST, Cooper ML, Foreman TJ. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate. JAMA 1989; 262: 2125-30.
17. 17 Eisinger M, Marko O. Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. Proc Natl Acad Sci USA 1982; 79: 2015-22.
18. 18 Halaban R, Alfano FD. Selective elimination of fibroblasts from cultures of normal human melanocytes. In Vitro Cell Development Biol Anim 1984; 20: 447-50.
19. 19 Boyce ST, Hansbrough JF. Biologic attachment and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate. Surgery 1988; 103: 421-31.
20. 20 Chen CJ, Lavker RM, Rodeck U et al. Use of a serum-free epidermal culture model to show deleterious effects of epidermal growth factor on morphogenesis and differentiation. J Invest Dermatol 1995; 104: 107-12.
21. 21 Le Poole IC, Das PK, Krieg SR et al. Organotypic culture of human skin for studying wound healing. Wounds 1991; 3: 102-10.
22. 22 Frazer A, Seid JM, Hart KA et al. Detection of mRNA for the transforming growth factor beta family in human articular chondrocytes by the polymerase chain reaction. Biochem Biophys Res Commun 1991; 180: 602-8.
23. 23 Satos RM, Norton P, Degli Eposti S, Zern MA. TGF-β isoforms in alcoholic liver disease. J Gastroenterol 1998; 33: 383-9.
24. 24 Arrick BA, Lopez AR, Elfman F et al. Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor β1. J Cell Biol 1992; 118: 715-26.
25. 25 Flanders KC, Thompson NL, Cissel DS et al. Transforming growth factor-β1: histochemical localization with antibodies to different epitopcs. J Cell Biol 1989; 108: 653-60.
26. 26 Barcellos-Hoff MH, Dix TA. Redox-mediated activation of latent transforming growth factor-β1. Molec Endocrinol 1996; 10: 1077-83.
27. 27 Housinger TA, Hills J, Warden GD. Management of pediatric facial burns. J Burn Care Rehabil 1994; 15: 408-11.
28. 28 Robson MC, Barnett RA, Leitch IOW, Hayward PG. Prevention and treatment of postburn scars and contracture. World J Sury 1992; 16: 87-96.